Although similar phenotypically, there is evidence that male and female breast cancer differ
in their molecular landscapes. In this systematic review, we consolidated all existing …

Male breast cancer (BC) represents less than 1% of male tumors. Little is known about male
BC characteristics, management, and survival, with many studies based on a small number …

Male breast cancer represents about 1% of all breast cancer diagnoses and, although there
are some similarities between male and female breast cancer, the paucity of data available …

BACKGROUND Male breast cancer (MBC) is an extremely rare condition and accounts for
less than 1% of all breast cancers, and malignant tumors occur in less than 1% of the …

Overexpression of the receptor tyrosine kinase HER2 (ERBB2) leads to an aggressive form
of breast cancer. In the past two decades many HER2-targeted therapies have been …

A relevant percentage of breast cancers (BCs) are tied to pathogenetic (P)/likely
pathogenetic (LP) variants in predisposing genes. The knowledge of P/LP variants is an …